Browse By: Country ι Category ι Latest Reports ι Tag

Laryngeal Cancer Global Clinical Trials Review, H2, 2012

Pages » 74
Published By » GlobalData
Price » $2500
In stock
View Report Details
Description

Laryngeal Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, Laryngeal Cancer Global Clinical Trials Review, H2, 2012" provides data on the Laryngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Laryngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Laryngeal Cancer.... Click here for more details


Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
GBI Research’s report, “Sales Force  Effectiveness in Pharmaceuticals - Cost Pressures Increases Pharmaceutical Companies\' Adoption of New Sales Models and Technologies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes t
Published Date: Oct 2010
Price: $3500
Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns
GBI Research, the leading business intelligence provider, has released its latest report, “Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns” that provides key data, information and analysis of the major tre
Published Date: Oct 2010
Price: $3500
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information and analysis on the pharmaceutical analytical services outsourcing in in
Published Date: Nov 2010
Price: $3500
Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets
GBI Research’s new report, “Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets”, provides in-depth analysis of various patent protection strategies adopted by pharmaceutical companies for maximizing revenues re
Published Date: Dec 2010
Price: $3500
Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market
GBI Research, a leading business intelligence provider, has released its latest research, “Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market”. The report provides in-depth analysis of the unmet needs, drivers and barriers
Published Date: Dec 2010
Price: $3500
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
GBI Researchs new report, Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategie
Published Date: Jan 2011
Price: $3500
Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth
GBI Research has released its pharmaceutical report, Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth that provides key data, information and analysis of the major trends and issues affecting the clinical trial market
Published Date: Apr 2011
Price: $3500
Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market
GBI Research, the leading business intelligence provider, has released its latest research Sleep Disorders Market to 2017- Generics Substitution Coupled with a Weak Pipeline Will Negatively Impact the Market, which provides insights into sleep disorders therapeutics sales and price forecasts u
Published Date: Apr 2011
Price: $3500
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
GBI Research has released its research, Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost, which provides insights into recruitment strategies, challenges and solutions for on-
Published Date: May 2011
Price: $3500
ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders
GBI Researchs pharmaceutical report, ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders provides in-depth analysis of unmet needs, drivers and barriers that impact the global ENT disorders market. The report ana
Published Date: Apr 2011
Price: $3500

 


 

Related News

Hygiene Hypothesis Corroborates Spike in Demand for Allergy Diagnostics
The global allergy diagnostic market has been booming over the past few years due to a proposed hygiene hypothesis. The theory claims that lack of exposure to allergens and dust or living in excessively hygienic conditions can make the human body prone to allergies as the immune system does not learn to fight. This theory has been proposed to back the increasing number of asthma cases amongst children, especially in the developed countries, where hygiene is given importance above its due. In add
Date: Oct 24

Globally Warming to Encourage Spread of Lethal Bacteria in Oceans Globally
It has already become evident that the increasing ocean temperatures have been making individuals sick and this is only becoming worse now. The bacteria that loves warmth is now growing in large numbers and is posing disastrous impacts on the human health, as per a study published recently. The bacteria called as Vibrio bacteria has caused around eighty thousand illnesses as well as about hundred deaths within the U.S alone in the past few years. Exceptional Count of Vibrio Cases in Northern Eu
Date: Aug 10

Global Paracetamol and PAP Market Fights an Uphill Battle
Paracetamol has been one of the most commonly used drugs in modern medicine. It has been used in the treatment of the most common ailments, including fever, cold, arthritis, and also major epidemics such as the swine flu. Consumers have shown a high rate of consumption of paracetamol as it provides almost instant relief from symptoms, is available everywhere as a generic drug, and is available as an over the counter drug in most countries. This includes the nations in North America, where the co
Date: Feb 18

Next-generation Antifungal Drugs Hold Promise for Dermatophytoses, Newer Therapeutics Overcome Shortcomings of Early Drugs
In the U.S., onychomycosis poses as a major public health problem, as it is prevalent in 10% of the population and its associated morbidity. Although not life-threatening, the fungal infection is a dermatophytic invasion of the nail plate. The infection can be present in any component of the nail unit, which includes the bed, matrix, or plate. Pain, discomfort, and disfigurement are the notable signs of onychomycosis, which may lead to significant physical and occupational limitations. The condi
Date: Jan 25

Despite Rise in Number of Erectile Dysfunction Cases, Revenue Generation from ED Drugs to Decline
This is probably one of the few times when availability of certain drugs is actually hampering the growth of a certain section of the health care market. The erectile dysfunction drugs market, over the past few decades, has been driven by the rising incidence of erectile dysfunction caused by environmental and genetic factors. However, there are several forces in the coming years that are anticipated to negatively impact the erectile dysfunction drugs market, causing it to register a -4.50 per c
Date: Jan 22

Chipotle and Costco E.coli Outbreaks Point out the Need for Advanced Testing Kit
During the period from October 2015 to November 2015, over 50 customers have been affected with E.coli after eating at Chipotle locations across Washington, Kansas, Oregon, and Oklahoma. More recently, 80 college students in Boston fell sick with the norovirus after contracting it from a single Chipotle location. By the end of 2015, more than 350 people became sick after eating at Chipotle. In early November, just after the Chipotle case had made headlines, another E.coli outbreak was reported i
Date: Jan 20

What the Newly Found Ebola Antibodies Mean for the Healthcare Industry
In what could be perceived to be one of the greater breakthroughs in the field of medicine, researchers have engineered the first antibodies that have the ability to neutralize two strains of the deadly Ebola-causing virus. The research was conducted on mice and is considered to be a major step in achieving immunization against all strains of Ebola. The research was led by Dr. Jonathan Lai. He stated that it is a tremendous advance to achieve a broadly effective Ebola immunotherapy. This is bec
Date: Jan 14

California Considering Exempting ‘Tampon Tax’
Growing awareness towards sanitation and urbanization has boosted the demand from the global feminine hygiene products market. In regions, especially Asia Pacific, several health programs focussed to raise awareness about sanitation across rural areas has augmented the market growth. Key market players such as Proctor & Gamble and Johnson & Johnson have partnered with governments in countries such as India to increase awareness among women regarding menstruation related health concerns. Rising c
Date: Jan 12

Aurobindo Pharma Latest to Join Line of Generic Drug Makers of Norethindrone Acetate
The United States Food and Drugs Association has officially given the nod of approval to Aurobindo Pharma to manufacture, sell, and market generic variants of norethindrone acetate within the U.S. market. The U.S. health regulator has provided Aurobindo Pharma with the vital agreement to create 5 mg strength tablets of norethindrone acetate, as said by an Aurobindo Pharma spokesperson in a recent statement. They later added that the drug has an estimated market size of US$42 mn for the twelve m
Date: Jan 11

Oral Contraceptive Pills Market Witnessing Surging Demand Particularly from Developed Regions
The market segment of oral contraceptive pills in the pharmaceutical industry is gearing to exhibit an exponential growth in the near future. The latest market studies published reveal promising growth prospects for the niche is very promising particularly due to the rising awareness about the pregnancy preventive methods, their corresponding benefits, and favorable reimbursement policies introduced by the policy makers.  Among the most prominent brands available in the market Loestrin and Bay
Date: Jan 07

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency
Price: $5795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency
Price: $5795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency
Price: $5795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency
Price: $5795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency
Price: $5795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency
Price: $5795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency
Price: $5795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency
Price: $5795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency
Price: $5795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency
Price: $5795